Search Videos and More
Sarcoidosis Case StudyBernard is a 37-year-old man with sarcoidosis initially diagnosed by lung biopsy in 2009. The sarcoidosis affects his skin, lungs, lymph nodes, and liver. He was referred to the Temple Lung Center for a lung transplantation evaluation due to severe pulmonary hypertension and poor exercise capacity. He had severe dyspnea, chronic dry cough, and chest tightness, as well as palpitation and dizziness. His constitutional symptoms included weight loss and fatigue.
Interstitial Lung Disease Program Referral InformationPatients with interstitial lung disease require care from a multidisciplinary team of experienced physicians, an active research program, and a commitment to patient education. The Temple Lung Center’s Interstitial Lung Disease Program is a national leader in all three areas, offering a physician leadership team with decades of experience at Temple, a research program that publishes often and is supported by the NIH and private industry, and a wide range of educational programs for patients, caregivers and physicians.
Tracheobronchial Malacia Referral InformationThe Tracheobronchomalacia (TBM) Program at the Temple Lung Center offers patients with this rare and often under-recognized condition, a multidisciplinary medical team led by specialty-trained thoracic surgeon Charles Bakhos, MD, FACS.
Management of Early Stage Non-Small Cell Lung CancerPresented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education, this conference is designed as a forum for discussion of advances in technology and treatment of early stage non-small cell lung cancer. Multidisciplinary perspectives, including medical, surgical and radiation oncology, pulmonology and radiology will be presented.
The Potential for Bronchoscopic Interventions in Chronic BronchitisChronic bronchitis is a clinical diagnosis characterized by chronic cough and phlegm production. It is typically associated with cigarette smoking and puts individuals at risk for respiratory exacerbations, reduces health related quality of life, and mortality. Current treatment options are limited and are largely ineffective. This program will focus on the new bronchoscopic interventions that are under development for the treatment of chronic bronchitis.
Alpha-One Antitrypsin Deficiency and Ascending Aortic DistentionFriederich Kueppers, MD discusses a study indicating a link between Alpha-One Antitrypsin Deficiency and Aortic Aneurysm.
Pulmonary Hypertension: An update on diagnosis, treatment and risk assessmentPulmonary hypertension encompasses a broad scope of disease states. This program will focus on pulmonary arterial hypertension (PAH) which begins as a vasculopathy within the small pulmonary arteries.
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) DiseaseNon-tuberculous mycobacteria (NTM), particularly Mycobacterium avium complex (MAC), has become increasingly more prevalent in patients causing pulmonary dysfunction.
Diaphragm DysfunctionWhile respiratory muscle dysfunction is well-documented, it’s often an underdiagnosed cause of dyspnea, and requires a multidisciplinary approach. Sources range from focal diaphragm dysfunction to systemic neuromuscular disease, often with overlooked symptoms and delayed diagnosis. This CME activity is divided into three sections, with a focus on general approach and diagnostic modalities for patients with suspected respiratory muscle impairment, surgical interventions for unilateral diaphragm dysfunction, and evaluation and treatment of systemic neuromuscular diseases.
Lung Cancer Screening and SPN in the Patient with COPDPatients with advanced Chronic Obstructive Pulmonary Disease (COPD) are at increased risk of lung cancer, and should be screened with low-dose CT.
Bronchoscopic Lung Volume Reduction - A conversation with national expert - Gerard J. Criner, MD - Podcast recorded by the American Association for Bronchology & International PulmonologyIn this podcast recorded by the American Association of Bronchology and Interventional Pulmonology, Gerard J. Criner, MD discusses patient selection for Bronchoscopic Lung Volume Reduction.
Targeted Lung DenervationGerard J. Criner, MD, FACP, FACCP, discusses the AIRFLOW-3 study which evaluates the efficacy of targeted lung denervation for patients with COPD.